These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37689996)

  • 1. Augmenting Immunotherapy via Bioinspired MOF-Based ROS Homeostasis Disruptor with Nanozyme-Cascade Reaction.
    Wang R; Qiu M; Zhang L; Sui M; Xiao L; Yu Q; Ye C; Chen S; Zhou X
    Adv Mater; 2023 Dec; 35(49):e2306748. PubMed ID: 37689996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy.
    Yang H; Xu G; Li F; Guo G; Yan P; Chen Y; Chen Y; Sun W; Song W; Zhong W
    Adv Sci (Weinh); 2024 Nov; 11(44):e2408729. PubMed ID: 39382153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PdPtCu Nanozymes for Reprogramming Tumor Microenvironment to Boost Immunotherapy Through Endoplasmic Reticulum Stress and Blocking IDO-Mediated Immune Escape.
    Xie Y; Wang M; Qian Y; Li L; Sun Q; Gao M; Li C
    Small; 2023 Nov; 19(44):e2303596. PubMed ID: 37394715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.
    Zhao Z; Dong S; Liu Y; Wang J; Ba L; Zhang C; Cao X; Wu C; Yang P
    ACS Nano; 2022 Dec; 16(12):20400-20418. PubMed ID: 36441901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
    Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
    ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief.
    He M; Zhang M; Xu T; Xue S; Li D; Zhao Y; Zhi F; Ding D
    J Control Release; 2024 Apr; 368():233-250. PubMed ID: 38395154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
    Lv W; Cao M; Liu J; Hei Y; Bai J
    Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen Sulfide Gas Amplified ROS Cascade: FeS@GOx Hybrid Nanozyme Designed for Boosting Tumor Chemodynamic Immunotherapy.
    Sun W; Zhu C; Song J; Ji SC; Jiang BP; Liang H; Shen XC
    Adv Healthc Mater; 2023 Sep; 12(23):e2300385. PubMed ID: 37040018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cu
    Xu H; Su Z; Zhang H; Zhang Y; Bao Y; Zhang H; Wu X; Yan R; Wang Z; Jin Y
    Int J Pharm; 2023 Jun; 640():123002. PubMed ID: 37254284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy.
    Su Z; Xu H; Zhang Y; Zhang H; Zhang H; Bao Y; Wu X; Yan R; Tan G; Wang Z; Jin Y
    J Mater Chem B; 2023 May; 11(19):4211-4226. PubMed ID: 37114499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation/Chemodynamic /Immunotherapy.
    Wang M; Chang M; Li C; Chen Q; Hou Z; Xing B; Lin J
    Adv Mater; 2022 Jan; 34(4):e2106010. PubMed ID: 34699627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment-activated single-atom platinum nanozyme with H
    Xu Q; Zhang Y; Yang Z; Jiang G; Lv M; Wang H; Liu C; Xie J; Wang C; Guo K; Gu Z; Yong Y
    Theranostics; 2022; 12(11):5155-5171. PubMed ID: 35836808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing the immunosuppressive microenvironment with reduced redox level by microwave-chemo-immunostimulant Ce-Mn MOF for improved immunotherapy.
    Zeng Z; Fu C; Sun X; Niu M; Ren X; Tan L; Wu Q; Huang Z; Meng X
    J Nanobiotechnology; 2022 Dec; 20(1):512. PubMed ID: 36463157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.
    Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P
    ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Spark" PtMnIr Nanozymes for Electrodynamic-Boosted Multienzymatic Tumor Immunotherapy.
    Li D; Ha E; Zhou Z; Zhang J; Zhu Y; Ai F; Yan L; He S; Li L; Hu J
    Adv Mater; 2024 Mar; 36(13):e2308747. PubMed ID: 38108600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
    Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
    Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifunctional cascade bioreactor based on a layered double oxides composite hydrogel for synergetic tumor chemodynamic/starvation/photothermal therapy.
    Xu R; Zhang D; Tan J; Ge N; Liu D; Liu J; Ouyang L; Zhu H; Qiao Y; Qiu J; Zhu S; Liu X
    Acta Biomater; 2022 Nov; 153():494-504. PubMed ID: 36115653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.
    Zhu L; Dai Y; Gao L; Zhao Q
    Int J Nanomedicine; 2021; 16():4559-4577. PubMed ID: 34267513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multifunctional Cascade Bioreactor Based on Hollow-Structured Cu
    Chang M; Wang M; Wang M; Shu M; Ding B; Li C; Pang M; Cui S; Hou Z; Lin J
    Adv Mater; 2019 Dec; 31(51):e1905271. PubMed ID: 31680346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.